Core Viewpoint - Reliance Global Group, Inc. will host a conference call on November 6, 2025, to discuss its third-quarter financial results and provide a business update [1]. Group 1: Conference Call Details - The conference call is scheduled for November 6, 2025, at 4:30 PM Eastern Time [1]. - U.S. callers can join the call by dialing +1 800-715-9871, while international callers can dial +1 646-307-1963 [2]. - A webcast of the call will be available on the company's investor relations website [2]. Group 2: Replay Information - A webcast replay will be accessible through the investor relations section of the company's website until November 6, 2026 [3]. - A telephone replay will be available approximately one hour after the call until November 20, 2025, with specific dialing instructions for U.S. and international callers [3]. Group 3: Company Overview - Reliance Global Group, Inc. is an InsurTech pioneer utilizing AI and cloud-based technologies to enhance efficiencies in the insurance agency and brokerage industry [4]. - The company's B2B platform, RELI Exchange, offers independent insurance agencies tools to compete with larger national agencies while reducing operational costs [4]. - The B2C platform, 5minuteinsure.com, provides quick online insurance quotes for auto, home, and life insurance using AI and data mining [4]. - The company also operates a portfolio of retail insurance agencies across the U.S., offering a variety of insurance products [4].

Expanding the Company’s Strategic Reach Across Defense, Diplomacy, and Technology InnovationWEST HOLLYWOOD, Calif. and TEL AVIV, Israel, Nov. 04, 2025 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV), a defense-technology and AI-driven sensing company, today announced the appointments of Admiral (Ret.) Eli Marum, former Commander-in-Chief of the Israeli Navy, and Ambassador (Ret.) Ned L. Siegel, former U.S. Ambassador to the Commonwealth of the Bahamas, to its Advisory Board. These distinguished ...

Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its third quarter 2025, for the period ended September 30, 2025, on Tuesday, November 11, 2025, before market ...

— Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7% — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $58.7M, +42% year-over-year growth; IFRS gross margin of 75.1% — First nine months IFRS and non-IFRS net income of $1.4M and $3.2M, respectively, versus a net loss of $3.8M and $2.1M, respectively, in the same year ago period — Approximately 667,00 pulse treatments administered since commer ...

VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Leviathan Gold Ltd. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce that it has received conditional approval of the TSX Venture Exchange (the “TSXV”) with respect to the previously announced proposed acquisition (the “Transaction”) of all of the issued and outstanding securities of Cura Exploration Botswana Corp. (“Cura”), further to its previous announcements on June 19, 2025, July 16, 2025, August 18 ...

Core Viewpoint - TELA Bio, Inc. is set to report its third quarter 2025 financial results on November 13, 2025, and will host a conference call and webcast to discuss these results and provide a corporate update [1]. Group 1: Financial Reporting - The third quarter 2025 financial results will be reported on November 13, 2025 [1]. - A conference call and webcast will take place at 4:30 p.m. ET on the same day to discuss the financial results [1]. Group 2: Company Overview - TELA Bio, Inc. is a commercial-stage medical technology company focused on innovative soft-tissue reconstruction solutions [3]. - The company aims to optimize clinical outcomes by preserving and restoring the patient's own anatomy, minimizing long-term exposure to synthetic materials [3].

LOWELL, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced that it has entered into an agreement with HRL Laboratories (“HRL”) to license and manufacture HRL’s proprietary 40nm T3L GaN-on-silicon carbide (“GaN-on-SiC”) process technology. HRL and MACOM will work collaboratively on a rapid process transfer of this proprietary semiconductor process from HRL’s facility to one of MACOM’s U.S. Trusted Foundries. Under ...

Core Points - Landsbankinn hf. announced the results of a tender offer for its EUR 2027 notes, inviting holders to tender their notes for cash payment [1] - The bank received valid tenders amounting to EUR 281,590,000, all of which were accepted [1] - The joint lead managers for the tender offer include ABN AMRO Bank, BofA Securities Europe, Natixis, and NatWest Markets [1] Additional Information - Further details regarding the tender offer results can be found in the announcement published on Euronext Dublin, where the bonds are listed [2] - The announcement contains information that may qualify as inside information under the Market Abuse Regulation [3]

Hereby please find the Annual Report 2024/25 for the group of Coloplast A/S. Attachment 11_2025_Annual_Report_2024-25 ...

Core Insights - Amazon's CEO Andy Jassy has highlighted "AI and agentic commerce" as the next major transformation in online shopping, validating Rezolve Ai's long-term efforts in this area [1][2][4] - Rezolve Ai has developed a three-layer Agentic Commerce architecture that supports autonomous transactions and decision-making for consumers, positioning the company as a leader in this emerging market [3][4] Company Overview - Rezolve Ai (NASDAQ: RZLV) specializes in AI-powered solutions aimed at enhancing customer engagement, operational efficiency, and revenue growth, focusing on the Agentic Commerce sector [5] - The company has created the Brain Suite, the first enterprise AI platform designed specifically for Agentic Commerce, which facilitates advanced functionalities such as search, transaction, fulfillment, and personalization on a global scale [5] Market Position - With Amazon's endorsement, Rezolve Ai is seen as having a first-mover advantage in the Agentic Commerce space, which is anticipated to be a trillion-dollar market [4] - The company is already engaged in live deployments with major retailers and payment providers, integrating with tech giants like Microsoft and Google to ensure secure operations across various ecosystems [3][4]